October 30, 2019 Off

Amgen recenues drop 3% in Q3 2019

By Dino Mustafić

Amgen said in a press release Tuesday it’s total revenues decreased 3% to $5.7 billion compared with the same period last year, reflecting the impact of biosimilar and generic competition against key products.